KRYS Stock Analysis: Buy, Sell, or Hold?
KRYS - Krystal Biotech, Inc. Common Stock
$304.23
2.18 (0.72%)
▲
5d:
-3.82%
30d:
+10.25%
90d:
+16.21%
HOLD
MODERATE Confidence
Analysis Updated: May 21, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When KRYS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KRYS is fairly valued with market pricing in 2.8% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: KRYS is fairly valued with market pricing in 2.8% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$444.16
Based on 12.2% avg growth
INTRINSIC VALUE TODAY
$275.79
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: KRYS is currently trading at $304.23, which is considered extended relative to its 30-day fair value range of $266.98 to $302.17. The stock's valuation (Forward PE: 30.2) is in line with its historical norms (27.8). At these levels, the market is pricing in 2.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, KRYS is in a uptrend. Immediate support is located at $286.00, while resistance sits at $319.48.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KRYS is in a uptrend. Immediate support is located at $286.00, while resistance sits at $319.48.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$266.98 -
$302.17
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.3%
Protect Your Profits
Holding KRYS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($322.78)
- NEUTRAL: Market pricing in 2.8% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$266.98 -
$302.17
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$16.30
(5.4%)
Support & Resistance Levels
Support Level
$286.00
Resistance Level
$319.48
Current Trend
Uptrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.18
Wall Street Target
$322.78
(+6.1%)
Revenue Growth (YoY)
31.9%
Earnings Growth (YoY)
52.5%
Profit Margin
53.9%
Valuation Premium vs History
+2.8% premium
PE vs Historical
30.2 vs 27.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.8%
(market-implied from PE analysis)
1-Year Target
$312.75
(+3%)
2-Year Target
$321.51
(+6%)
3-Year Target
$330.51
(+9%)
3-Yr Target (if PE normalizes)
(PE: 30→28)
PE COMPRESSION
$304.44
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.2, Growth: 20.3%)
$530.29
(+74%)
Base:
(SPY PE: 22.0, Growth: 20.3%)
$386.38
(+27%)
Bear:
(PE: 18.7, Growth: 20.3%)
$328.42
(+8%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (40x PE), but valuation improves significantly next year (30x PE) as earnings recover.
Trailing PE: 40.26 | Current EPS (TTM): $7.46
Bull Case
$446.40
(+47%)
Analyst growth 35.1%, PE expands to 44.3
Base Case
$405.82
(+33%)
Market implied 35.1%, PE stable at 40.3
Bear Case
$204.22
(-33%)
Severe decline -20.0%, PE contracts to 34.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 21, 2026 8:30 PM ET
Data refreshes hourly during market hours. Next update: 9:30 PM
Data refreshes hourly during market hours. Next update: 9:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KRYS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Suma Krishnan
SELL
25000 shares
2026-03-04
Kathryn Romano
SELL
750 shares
2026-03-02
Daniel Janney
SELL
11803 shares
2026-02-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 51 HOLD |
Advanced KRYS Option Strategies
Professional options setups generated by AI based on today's KRYS price and gamma walls.
